Search Results for

Clear All Filters

March 07, 2025

Timi Iwayemi

Newsletter Corruption CalendarCryptocurrencyEthics in GovernmentFinancial RegulationHealthRevolving Door

Week Seven: One Nation Under God, Indivisible

The seventh week of Trump’s presidency was a stark reminder of how little the public’s wellbeing factors into his administration’s decisions. This week, the administration reiterated its position that it’s open season for corporate predators, RFK Jr. moved to abolish public input into public health regulations, co-president Elon Musk found new ways to exploit the federal contracting system, banking regulators chose Wall Street over Main Street, and a corporate lobbyist stepped in to facilitate the sale of precious public lands to lumber companies.

February 20, 2025

Emma Marsano

Blog Post DOGEHealthPharmaTrump 2.0

DOGE Envisions A Future Without Critical Public Health Services

After a week of rumors that the Trump administration was planning to implement severe cuts to the Department of Health and Human Services (HHS), it happened—though the White House reportedly denied that it would. This past Friday, senior officials were informed that 5200 relatively recent hires would be fired across multiple agencies at HHS, with 1300 at the CDC specifically. 

May 10, 2024

Fatou Ndiaye

Blog Post Climate and EnvironmentFEMAGovernment CapacityHealthIRS

Four executive branch agencies that desperately need more funding and staffing

Across the federal government, we continue to see how staffing issues are preventing agencies from fulfilling their mandate, at the expense of the public and to the benefit of corporate wrongdoers. The Food and Drug Administration (FDA), The Federal Emergency Management Agency (FEMA), The Environmental Protection Agency (EPA), and The Internal Revenue Service (IRS) are 4 agencies that desperately need more funding and staffing to protect and do right by the American people.

February 06, 2024

Timi Iwayemi

Public Comment Department of CommerceExecutive BranchHealthPharma

Civil Society Comment on the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

Unfortunately, despite numerous petitions presented over the 40-plus year history of the Bayh-Dole Act, not once has a federal agency exercised its right to march-in and license competition to remedy price gouging (which constitutes a failure of the owner of a subject invention to make that invention available to the public on reasonable terms), or otherwise.

September 27, 2023 | Revolving Door Project Newsletter

KJ Boyle

Newsletter Climate and EnvironmentCorporate CrackdownGovernment CapacityHealth

New Watchdog Reports Highlight Insufficient EPA Enforcement Ahead Of Shutdown

Corporate greed and emaciated federal regulatory capacity means people are needlessly suffering physically, and sometimes even dying. That’s the upshot of two recent reports from the EPA’s Office of the Inspector General (OIG). These reports illustrate the concerning state of environmental regulation and enforcement in regards to water quality and refinery emissions. 

September 18, 2023

Hannah Story Brown Dorothy Slater

Press Release Climate and EnvironmentExecutive BranchHealth

RELEASE: White House Should Deepen Its New Recognition of the Environmental Salience of Its Cancer Moonshot Initiative

The White House announced late last week that the Environmental Protection Agency is launching epa.gov/cancer as part of the Biden administration’s Cancer Moonshot efforts, and will share new information about the EPA’s role in leveraging its existing authorities to “accelerate the rate of progress to prevent cancer, including phase-outs of carcinogens, regulatory actions to protect children, workers and overburdened communities, and enforcement actions to ensure pollution is curbed.”